Humacyte (HUMA) News Today $4.41 -0.01 (-0.23%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud LawsuitNovember 21 at 2:06 AM | gurufocus.comHUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud LawsuitNovember 20 at 6:27 PM | prnewswire.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of HumacyteNovember 20 at 5:50 PM | tmcnet.comGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Humacyte, Inc. (HUMA)November 20 at 4:26 PM | globenewswire.comThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc. (HUMA) InvestorsNovember 20 at 12:48 PM | tmcnet.comHUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law FirmNovember 20 at 12:27 AM | tmcnet.comHumacyte (HUMA) Faces Class Action Lawsuit After FDA Inspection Reveals Manufacturing Issues- Hagens BermanNovember 20 at 12:27 AM | markets.businessinsider.comHUMACYTE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humacyte, Inc. and Encourages Investors to Contact the FirmNovember 19 at 9:00 PM | globenewswire.comInvestor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Humacyte, Inc.November 19 at 8:00 PM | prnewswire.comKirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc. (HUMA) InvestorsNovember 19 at 5:03 PM | businesswire.comHUMA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Humacyte, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitNovember 19 at 4:00 PM | globenewswire.comRosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their RightsNovember 19 at 2:18 PM | businesswire.comSHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Humacyte, Inc. (HUMA) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmNovember 19 at 11:30 AM | globenewswire.comHumacyte’s sdATEV device shows efficacy in artery bypass trial in primatesNovember 18 at 11:47 PM | markets.businessinsider.comPromising Prospects for Humacyte: Analyst Projects Growth Potential with ATEV InnovationsNovember 18 at 11:47 PM | markets.businessinsider.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc. (HUMA) InvestorsNovember 18 at 10:34 PM | businesswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humacyte, Inc. - HUMANovember 18 at 9:52 PM | prnewswire.comHumacyte (HUMA) Faces Class Action Lawsuit After FDA Inspection Reveals Manufacturing Issues– Hagens BermanNovember 18 at 8:04 PM | globenewswire.comHUMA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Humacyte, Inc.November 18 at 6:04 PM | businesswire.comHumacyte's (HUMA) "Buy" Rating Reaffirmed at HC WainwrightNovember 17, 2024 | americanbankingnews.comHC Wainwright Issues Negative Estimate for Humacyte EarningsNovember 16, 2024 | americanbankingnews.comHumacyte's (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens BermanNovember 15, 2024 | globenewswire.comHumacyte prices 2.8M shares at $5.34 in registered direct offeringNovember 15, 2024 | markets.businessinsider.comHumacyte Advances with $15M Direct OfferingNovember 15, 2024 | markets.businessinsider.comHC Wainwright Has Negative View of Humacyte FY2024 EarningsHumacyte, Inc. (NASDAQ:HUMA - Free Report) - Equities research analysts at HC Wainwright lowered their FY2024 EPS estimates for Humacyte in a research note issued to investors on Wednesday, November 13th. HC Wainwright analyst V. Bernardino now forecasts that the company will post earnings per shNovember 15, 2024 | marketbeat.comFY2024 EPS Estimates for Humacyte Cut by Cantor FitzgeraldHumacyte, Inc. (NASDAQ:HUMA - Free Report) - Stock analysts at Cantor Fitzgerald reduced their FY2024 EPS estimates for shares of Humacyte in a research note issued to investors on Monday, November 11th. Cantor Fitzgerald analyst K. Kluska now forecasts that the company will post earnings of ($1.November 14, 2024 | marketbeat.comHumacyte Announces Pricing of $15.0 Million Registered Direct OfferingNovember 14, 2024 | finance.yahoo.comHumacyte’s Strategic Progress and Market Potential Justify Buy Rating, Says AnalystNovember 13, 2024 | markets.businessinsider.comHumacyte's (HUMA) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $12.00 price target on shares of Humacyte in a research note on Wednesday.November 13, 2024 | marketbeat.comHUMACYTE ALERT: Bragar Eagel & Squire, P.C. is Investigating Humacyte, Inc. on Behalf of Humacyte Stockholders and Encourages Investors to Contact the FirmNovember 12, 2024 | globenewswire.comHumacyte (HUMA) Faces Questions After FDA Inspection – Hagens BermanNovember 11, 2024 | globenewswire.comHumacyte, Inc. (NASDAQ:HUMA) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | msn.comBenchmark Co. Sticks to Their Buy Rating for Humacyte (HUMA)November 11, 2024 | markets.businessinsider.comHumacyte Faces Financial Uncertainty: Potential Impact on Share Price and CapitalNovember 11, 2024 | msn.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humacyte, Inc. - HUMANovember 10, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humacyte, Inc. - HUMANovember 10, 2024 | prnewswire.comHumacyte, Inc. (HUMA) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comHumacyte Inc (HUMA) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesNovember 9, 2024 | finance.yahoo.comHumacyte Reports Q3 2024 Results Amid FDA ReviewNovember 9, 2024 | markets.businessinsider.comHumacyte (NASDAQ:HUMA) Trading 11% Higher - Should You Buy?Humacyte (NASDAQ:HUMA) Trading Up 11% - Here's What HappenedNovember 8, 2024 | marketbeat.comPreview: Humacyte's EarningsNovember 8, 2024 | benzinga.comHumacyte's (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens BermanNovember 8, 2024 | globenewswire.comHumacyte Third Quarter 2024 Financial Results and Business UpdateNovember 8, 2024 | globenewswire.comHumacyte (HUMA) to Release Earnings on FridayHumacyte (NASDAQ:HUMA) will be releasing earnings before the market opens on Friday, November 8, Zacks reports.November 7, 2024 | marketbeat.comEquities Analysts Offer Predictions for Humacyte Q3 EarningsHumacyte, Inc. (NASDAQ:HUMA - Free Report) - Analysts at HC Wainwright issued their Q3 2024 earnings per share (EPS) estimates for Humacyte in a research note issued on Tuesday, November 5th. HC Wainwright analyst V. Bernardino forecasts that the company will post earnings of ($0.26) per share foNovember 7, 2024 | marketbeat.comThe Law Offices of Frank R. Cruz Continues Its Investigation of Humacyte, Inc. (HUMA) on Behalf of InvestorsNovember 6, 2024 | tmcnet.comHC Wainwright Forecasts Humacyte FY2028 EarningsHumacyte, Inc. (NASDAQ:HUMA - Free Report) - Equities research analysts at HC Wainwright issued their FY2028 earnings per share (EPS) estimates for shares of Humacyte in a research note issued on Tuesday, November 5th. HC Wainwright analyst V. Bernardino anticipates that the company will post earNovember 6, 2024 | marketbeat.comHumacyte price target raised to $12 from $6 at H.C. WainwrightNovember 6, 2024 | markets.businessinsider.comHumacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 8, 2024November 6, 2024 | globenewswire.comHumacyte’s ATEV: Promising Clinical Performance and Market Potential Drive Buy RatingNovember 5, 2024 | markets.businessinsider.com Get Humacyte News Delivered to You Automatically Sign up to receive the latest news and ratings for HUMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide HUMA Media Mentions By Week HUMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HUMA News Sentiment▼-0.090.45▲Average Medical News Sentiment HUMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HUMA Articles This Week▼355▲HUMA Articles Average Week Get Humacyte News Delivered to You Automatically Sign up to receive the latest news and ratings for HUMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies EVLV News Today BARK News Today SST News Today IDYA News Today KROS News Today CGON News Today WVE News Today AKRO News Today AMPH News Today MIRM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HUMA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humacyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humacyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HUMA Stock Alerts